Skip to content

Predictive Factors of Failure or Success of Sedation With Dexmedetomidine in ICU

Predictive Factors of Failure or Success of Sedation With Dexmedetomidine in ICU

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02200159
Enrollment
200
Registered
2014-07-25
Start date
2014-06-30
Completion date
2015-12-31
Last updated
2014-11-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adult Patients, Patient Covered by French Health Care System, Requiring Sedation in ICU

Keywords

Sedation, Dexmedetomidine, ICU, Delirium

Brief summary

Research predictive factors of success or failure of a sedation with Dexmedetomidine in ICU

Detailed description

Prospective clinical study in ICU with sedated ventilated patients with dexmedetomidine, establishing incidence of success, failure of moderate sedation or failure of dexmedetomidine, to evaluate the effectiveness of this drug sedation in moderate sedation

Interventions

Sponsors

University Hospital, Clermont-Ferrand
Lead SponsorOTHER

Study design

Observational model
COHORT

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

-Adult patients ventilated requiring sedation in ICU with RASS objective more than -2

Exclusion criteria

* contraindication: intracranial lesion, hepatic failure * pregnancy

Design outcomes

Primary

MeasureTime frameDescription
Number of patients with failure of sedation with dexmedetomidineat day 1Number of patients with failure of sedation with dexmedetomidine (necessity to stop this sedation due to adverse event, RASS\>+1, other) in ICU patients requiring such sedation during ICU stay.

Secondary

MeasureTime frame
Incidence of adverse event of dexmedetomidineat day 1
Incidence of delirium and use of other sedative drugsat day 1

Countries

France

Contacts

Primary ContactPatrick LACARIN
placarin@chu-clermontferrand.fr04 73 75 11 95

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026